BlackRock Health Sciences Term Trust $BMEZ Stock Position Lifted by Readystate Asset Management LP

Readystate Asset Management LP grew its position in BlackRock Health Sciences Term Trust (NYSE:BMEZ) by 664.6% in the third quarter, according to its most recent 13F filing with the Securities and Exchange Commission. The fund owned 247,074 shares of the company’s stock after acquiring an additional 214,761 shares during the quarter. Readystate Asset Management LP’s holdings in BlackRock Health Sciences Term Trust were worth $3,563,000 as of its most recent filing with the Securities and Exchange Commission.

Other large investors also recently made changes to their positions in the company. Geneos Wealth Management Inc. bought a new position in BlackRock Health Sciences Term Trust in the 1st quarter valued at $40,000. Newbridge Financial Services Group Inc. bought a new position in shares of BlackRock Health Sciences Term Trust in the second quarter valued at approximately $69,000. Smartleaf Asset Management LLC bought a new position in shares of BlackRock Health Sciences Term Trust in the third quarter valued at approximately $91,000. B. Riley Wealth Advisors Inc. purchased a new stake in shares of BlackRock Health Sciences Term Trust in the 2nd quarter worth about $183,000. Finally, Baird Financial Group Inc. purchased a new position in shares of BlackRock Health Sciences Term Trust during the 1st quarter worth $189,000.

Insiders Place Their Bets

In other BlackRock Health Sciences Term Trust news, Director Robert W. Fairbairn sold 10,294 shares of the stock in a transaction that occurred on Thursday, December 18th. The shares were sold at an average price of $14.98, for a total value of $154,204.12. The sale was disclosed in a document filed with the SEC, which is available through this link.

BlackRock Health Sciences Term Trust Stock Performance

NYSE BMEZ opened at $14.93 on Wednesday. The company’s 50-day moving average price is $15.21 and its 200-day moving average price is $14.84. BlackRock Health Sciences Term Trust has a 12 month low of $12.58 and a 12 month high of $16.19.

BlackRock Health Sciences Term Trust Dividend Announcement

The business also recently announced a monthly dividend, which will be paid on Tuesday, March 31st. Investors of record on Friday, March 13th will be issued a $0.11 dividend. The ex-dividend date is Friday, March 13th. This represents a c) dividend on an annualized basis and a yield of 8.8%.

About BlackRock Health Sciences Term Trust

BlackRock Health Sciences Term Trust (NYSE: BMEZ) is a closed-end management investment company organized as a Delaware statutory trust. Launched in March 2020, BMEZ seeks to provide total return through a combination of current income and capital appreciation by investing primarily in equity and equity-related securities of companies in the health sciences sector. The trust is structured with a fixed termination date in October 2030, at which time shareholders will vote on its liquidation, extension or conversion.

The fund’s investment portfolio is diversified across subsectors within health sciences, including biotechnology, pharmaceuticals, medical devices, diagnostics and healthcare services.